
Semaglutide Peptide Therapy
Benefits, Side Effects, Cost & Protocols
Semaglutide is an anti-diabetic medication used for the treatment of type 2 diabetes, and an anti-obesity medication used for long-term weight management and to reduce the risk of major adverse cardiovascular events. It is a peptide similar to the hormone glucagon-like peptide-1 (GLP-1), modified with a side chain. It can be administered by subcutaneous injection or taken orally. Sold under the brand names Ozempic, Rybelsus, and Wegovy.
Clinically Reviewed
Reviewed by Alex Evans, PharmD, MBA · Updated June 2026
Evidence-Based
Sourced from FDA, PubMed & ClinicalTrials.gov · View sources
Compare Semaglutide Prices
33 providers offering Semaglutide — sorted lowest price first
We may earn a commission at no extra cost to you. Disclosure
Prices shown are estimates based on publicly available data and may not reflect current pricing. Actual costs may vary by location, insurance, dosage, and formulation. Always verify directly with the provider.
Who Is Semaglutide Best For?
How Semaglutide Works
GLP-1 receptor agonist that reduces appetite, slows gastric emptying, and improves insulin sensitivity for weight management.
Semaglutide FAQ
What is SEMAGLUTIDE?
Semaglutide is the GLP-1 agonist that revolutionized weight loss treatment. Following FDA resolution of shortages in 2025 and subsequent compounding restrictions, research-grade semaglutide has seen significant demand increases.
How does SEMAGLUTIDE work?
GLP-1 receptor agonist that reduces appetite, slows gastric emptying, and improves insulin sensitivity for weight management.
Is SEMAGLUTIDE legal to buy?
SEMAGLUTIDE requires a prescription from a licensed healthcare provider. It is legal to purchase with a valid prescription from authorized pharmacies.
Where can I buy SEMAGLUTIDE?
SEMAGLUTIDE is available by prescription through compounding pharmacies and telehealth providers. Browse our verified provider directory to find trusted sources.
What category does SEMAGLUTIDE belong to?
SEMAGLUTIDE is primarily classified as a weight loss & metabolic peptide. Peptides researched for their effects on weight management, fat metabolism, appetite regulation, and metabolic enhancement. This category includes GLP-1 agonists, dual/triple agonists, and other metabolic peptides.
What are the research benefits of SEMAGLUTIDE?
SEMAGLUTIDE has been studied for: Weight loss, Appetite suppression, Glycemic control, Metabolic health. GLP-1 classic; restricted compounding has increased research vendor demand.
Key Studies
4,895 total on PubMed2,823 human trialsSemaglutide and Cardiovascular Outcomes in Obesity without Diabetes
Lincoff AM, Brown-Frandsen K, Colhoun HM et al
N Engl J MedPhase 3
Semaglutide reduced cardiovascular events in obese patients with cardiovascular disease but without diabetes
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
McGuire DK, Marx N, Mulvagh SL et al
N Engl J MedPhase 3
Oral semaglutide reduced major adverse cardiovascular events vs placebo in high-risk type 2 diabetes
Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: Design and baseline characteristics of SOUL, a randomized trial
McGuire DK, Busui RP, Deanfield J et al
Diabetes Obes Metab · Diabetes Obes MetabPhase 3
SOUL trial design for assessing oral semaglutide effects on cardiovascular outcomes in type 2 diabetes with atherosclerotic disease and/or chronic kidney disease
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
Semaglutide Compound Data
Semaglutide News
The Science Behind the Quest for a Non-Peptide Oral Weight Loss Drug A - American Council on Science and Health
American Council on Science and Health · 4 days ago
Optimised semaglutide formulation could advance peptide-based oral delivery - European Pharmaceutical Review
European Pharmaceutical Review · 16 days ago
GLP-1 Weight-Loss Pills: What You Need to Know - Yale Medicine
Yale Medicine · 1 month ago
Fibrillar and Micellar Aggregation of Semaglutide and Formation of a Chiral-Imprinted Glass - ACS Publications
ACS Publications · 2 months ago
Novo Nordisk's Ozempic® pill, the only FDA-approved oral peptide GLP-1 medication for adults with type 2 diabetes, soon to be available in the US - PR Newswire
PR Newswire · 1 month ago
News aggregated via Google News. Inclusion does not imply endorsement.
Ready to explore Semaglutide with a provider?
Take our 2-minute quiz to get matched with a board-certified provider specializing in Semaglutide.
Take the Quiz →